Physician profile
Vijay Das
NPI 1972532497
$1,096.03
in general payments reported to CMS, 2019-2025
19 companies · $85.00 in 2025
The $85.00 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $37.41 · 2021: $182 · 2022: $17.04 · 2023: $240 · 2024: $110 · 2025: $85.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $220.66 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $132.35 | 2019-2025 | Fasenra |
| Actelion Pharmaceuticals US, INC. | $120.60 | 2019-2021 | |
| Abiomed | $101.74 | 2023 | Impella |
| Intuitive Surgical, INC. | $97.84 | 2023 | Da Vinci Surgical System |
| Mallinckrodt Enterprises LLC | $71.73 | 2019 | |
| Abbvie INC. | $56.64 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $49.94 | 2023-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.75 | 2019 | |
| Pfizer INC. | $29.82 | 2021-2024 | |
| Insmed, INC. | $27.30 | 2019 | |
| Csl Behring | $24.09 | 2025 | Kcentra |
| Shire North American Group INC | $23.41 | 2019 | |
| Grifols USA, LLC | $23.21 | 2020 | |
| Merck Sharp & Dohme LLC | $19.09 | 2025 | Zerbaxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $17.44 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.73 | 2025 | Nuzyra |
| La Jolla Pharmaceutical Company | $15.10 | 2021 | |
| Philips North America LLC | $14.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.